Skip to contentSkip to Braille Studio

Library / Laws / 119th Congress / House Bills / H.R. 1405

H.R. 1405

To direct the Comptroller General of the United States to conduct a study to assess the key regulatory barriers that impede the expansion or siting of new pharmaceutical manufacturing facilities in the United States, and for other purposes.

Print stageDateSize⠃
Introduced in House2025-02-182.9K⠃⠗⠋